Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Mologen AG. (11/12/18). "Press Release: Lefitolimod – First Clinical Data in Combination with a Checkpoint Inhibitor and further Preclinical Results Presented at SITC 2018". Berlin. 2018-11-12
Medigene AG. (11/12/18). "Press Release: Medigene Reports Financial & Business Results for the First Nine Months of 2018". Planegg. 2018-11-12
Aimmune Therapeutics, Inc.. (11/12/18). "Press Release: Aimmune Therapeutics Announces Additional Equity Investment by Nestlé Health Science". Brisbane, CA. 2018-11-12
Medigene AG. (11/12/18). "Press Release: Medigene Signs Exclusive License Agreement with Leiden University to Develop Novel T Cell Receptor". Martinsried. 2018-11-12
Merck KGaA. (11/12/18). "Press Release: Merck Paves the Way for Its Innovation Hub in Southern China". Darmstadt & Guangzhou. 2018-11-12
Scienion AG. (11/9/18). "Press Release: R2R Biofluidics EU Project Recently Received the Austrian Fast Forward Award 2018". Berlin. 2018-11-09
Arsanis, Inc.. (11/9/18). "Press Release: Arsanis Reports Financial Results for Third Quarter 2018". Waltham, MA & Vienna. 2018-11-09
CRISPR Therapeutics AG. (11/9/18). "Press Release: CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology". Zug, Cambridge, MA & Gaithersburg, MD. 2018-11-09
Convert Pharmaceuticals S.A.. (11/8/18). "Press Release: Convert Pharmaceuticals Appoints Mariola Söhngen as New CEO". 2018-11-08
Themis Bioscience N.V.. (11/8/18). "Press Release: Themis Bioscience Postpones Its Listing on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna. 2018-11-08
Mologen AG. (11/8/18). "Press Release: Implementation of Financing Measures and Publication of Study Results". Berlin. 2018-11-08
Curetis N.V.. (11/7/18). "Press Release: Curetis Raises €8.9 Million through Private Placements [Not for United States, Australia, Canada, Japan or South Africa or any other Jurisdiction where unlawful]". Amsterdam, Holzgerlingen & San Diego, CA. 2018-11-07
CRISPR Therapeutics AG. (11/7/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results". Zug & Cambridge, MA. 2018-11-07
ProBioGen AG. (11/6/18). "Press Release: ProBioGen Announces Successful Bispecific GlymaxX Development Project for Zymeworks". Berlin. 2018-11-06
Spark Therapeutics, Inc.. (11/6/18). "Press Release: Spark Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Progress". Philadeliphia, PA. 2018-11-06
Nabriva Therapeutics plc. (11/6/18). "Press Release: Nabriva Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights". Dublin. 2018-11-06
Genedata AG. (11/6/18). "Press Release: Sartorius Stedim Cellca Licenses Genedata Bioprocess to Streamline Development Operations". Basel. 2018-11-06
BioNTech AG. (11/5/18). "Press Release: BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration to Develop mRNA Vaccine Candidates against Various Infectious Diseases". Mainz. 2018-11-05
Immunic AG. (11/5/18). "Press Release: Immunic Enters into a Global Option and License Agreement with Daiichi Sankyo". Planegg-Martinsried. 2018-11-05
Boehringer Ingelheim. (11/5/18). "Press Release: Initial Results from EMPRISE Real-world Evidence Study". Ingelheim & Indianapolis, IN. 2018-11-05
Themis Bioscience GmbH. (11/5/18). "Press Release: Themis Bioscience Publishes Compelling Phase 2 Results for Lead Vaccine Candidate against Chikungunya Fever in The Lancet". Vienna. 2018-11-05
MorphoSys AG. (11/5/18). "Press Release: MorphoSys AG Announces Third Quarter 2018 Results". Planegg. 2018-11-05
Marinomed Biotech AG. (11/5/18). "Press Release: Marinomed Announces Its Intention to Launch an Initial Public Offering and Listing on the Vienna Stock Exchange [Not for US, AU, CA, JP, et al.]". Vienna. 2018-11-05
Centogene AG. (11/2/18). "Press Release: Centogene Further Expands Executive Team, Appoints Oved Amitay as Chief Business Officer – Increases Focus on Pharma Partnerships". Rostock. 2018-11-02
Curetis N.V.. (11/2/18). "Press Release: Curetis Launches Privately Placed Capital Increase to Raise up to €18.4 Million [NOT FOR THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL]". Amsterdam, Hol 2018-11-02
Omeicos Therapeutics GmbH. (11/2/18). "Press Release: Omeicos Therapeutics Closes €17m Series C Financing to Advance Lead Candidate OMT-28 Towards Pivotal Trials in Atrial Fibrillation". Berlin & Boston, MA. 2018-11-02
Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (11/2/18). "Press Release: Dr. Axel Mescheder Appointed CEO of Cristal Therapeutics as Focus Intensifies on Proprietary Oncology Nanomedicine Pipeline". Maastricht. 2018-11-02
Neurimmune AG. (11/1/18). "Press Release: Neurimmune Appoints Natascha Schill as VP Project and Alliance Management". Schlieren. 2018-11-01
Argen-X N.V. (Argenx). (11/1/18). "Press Release: Argenx Announces New Cusatuzumab (ARGX-110) AML Data in Abstracts Published in Connection with 60th American Society of Hematology Annual Meeting and Exposition". Breda & Ghent. 2018-11-01
Nabriva Therapeutics plc. (11/1/18). "Press Release: Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous Contepo to Treat Complicated Urinary Tract Infections". Dublin. 2018-11-01
[iito] Business Intelligence. (10/31/18). "Press Release: [iito] Discontinues Life-Sciences-Spain.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. 2018-10-31
PerkinElmer, Inc.. (10/31/18). "Press Release: PerkinElmer Announces Financial Results for the Third Quarter of 2018". Waltham, MA. 2018-10-31
Boehringer Ingelheim. (10/31/18). "Press Release: Boehringer Ingelheim Achieves Next Expansion Milestone in Biologics Production in the US". Fremont, CA. 2018-10-31
Grünenthal GmbH. (10/30/18). "Press Release: Grünenthal Agrees US$ 922 m Deal with AstraZeneca for Nexium and Vimovo". Aachen. 2018-10-30
Harpoon Therapeutics, Inc.. (10/30/18). "Press Release: Harpoon Therapeutics Announces Appointment of Ms. Georgia L. Erbez to Chief Financial Officer and Promotion of Holger Wesche, Ph.D., to Chief Scientific Officer". South San Francisco, CA. 2018-10-30
BioM Biotech Cluster Development GmbH. (10/30/18). "Pressemitteilung: BioM erhält Auftrag zur Projektkoordination von »DigiMed Bayern«. Bayerisches Gesundheitsministerium fördert das medizinische Digitalisierungsvorhaben mit 20 Millionen Euro über 5 Jahr 2018-10-30
Noscendo GmbH. (10/29/18). "Press Release: Noscendo Closes Financing Round for CE Certification and Market Entry Preparation of Platform Diagnostics for Bloodstream Associated Infections". Duisburg. 2018-10-29
Thermo Fisher Scientific Inc.. (10/29/18). "Press Release: Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins". Sunnyvale, CA. 2018-10-29
Themis Bioscience N.V.. (10/29/18). "Press Release: Themis Bioscience Launches its Initial Public Offering on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna. 2018-10-29
Boehringer Ingelheim. (10/26/18). "Press Release: Boehringer Ingelheim Inaugurates New Centre for Agile Working Methods – More and Better Health Solutions for Humans and Animals". Ingelheim. 2018-10-26
Galecto Biotech AB. (10/26/18). "Press Release: Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development". Copenhagen. 2018-10-26
Intrexon Corporation. (10/24/18). "Press Release: Intrexon Announces the Formation of Bioinformatics Hub in Munich. Establishing itself as Intrexon Bioinformatics Germany GmbH (IBG)". Germantown, MD. 2018-10-24
Magnisense SE. (10/24/18). "Press Release: Magnisense Successfully Raises € 5 Nillion to Boost the Commercial Development of Its MiAG Emergency Diagnostic Tests for Heart Diseases". Paris. 2018-10-24
BASF SE. (10/24/18). "Press Release: BASF Licenses CRISPR-Cpf1 Genome Editing Technology from the Broad Institute of MIT and Harvard". Research Triangle Park, NC. 2018-10-24
Novartis AG. (10/23/18). "Press Release: Alcon to Develop SMART Suite Digital Health Platform for Cataract Surgery". Fort Worth, TX. 2018-10-23
Idorsia Ltd.. (10/23/18). "Press Release: Idorsia Announces that Simon Jose Is to Join the Company as Chief Commercial Officer". Alschwil. 2018-10-23
Validogen GmbH. (10/22/18). "Press Release: Change of Company Name – VTU Technology Is Now Validogen". Raaba-Grambach. 2018-10-22
Marinomed Biotech AG. (10/19/18). "Press Release: Initiation of First Marinosolv Clinical Trial (Ph III)". 2018-10-19
Apceth Biopharma GmbH. (10/19/18). "Press Release: Apceth Biopharma Presents Positive Data Demonstrating Efficacy of Apceth-201 in Preclinical Models of Acute GvHD". Munich. 2018-10-19
Boehringer Ingelheim. (10/19/18). "Press Release: Real-world Study Shows Using Giotrif/Gilotrif (afatinib) Followed by Osimertinib Provides a Median of 27.6 Months of Chemotherapy-free Time in Patients with EGFR Mutation-positive NSCLC". Ingelheim. 2018-10-19
Protagen AG. (10/18/18). "Press Release: The National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Extend Their Collaboration to Investigate the Immuno-competence of Urothelial Cancer Patients Receiving Immunotherapy". 2018-10-18
Novartis AG. (10/18/18). "Press Release: Novartis Announces Planned Acquisition of Endocyte to Expand Expertise in Radiopharmaceuticals and Build on Commitment to Transformational Therapeutic Platforms". Basel. 2018-10-18
Novartis AG. (10/18/18). "Press Release: Novartis Delivered Strong Growth and Innovation During the Third Quarter, Including Progressing Advanced Therapy Platforms to Drive Future growth". Basel. 2018-10-18
Selexis S.A.. (10/18/18). "Press Release: Selexis and Berkeley Lights Collaborate to Accelerate Cell Line Development with the Beacon Optofluidic Platform". Geneva. 2018-10-18
OLS Omni Life Science GmbH & Co. KG. (10/18/18). "Press Release: CERO Is a Novel 3D Cell Cultivation System". Bremen. 2018-10-18
Oncgnostics GmbH. (10/17/18). "Press Release: Cervical Cancer Screening. Oncgnostics Closes further Investment Round". Jena. 2018-10-17
Quantum Analytics. (10/16/18). "Press Release: New Distribution Agreement with Bruker AXS". Foster City, CA. 2018-10-16
Bruker Corporation. (10/16/18). "Press Release: Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH". Billerica, MA. 2018-10-16
Bruker Corporation. (10/16/18). "Press Release: Bruker Launches the S2 Polar High-Performance, Multi-Element Benchtop EDXRF Analyzer for the Petrochemical Industry". Galveston, TX. 2018-10-16
ERS Genomics Ltd.. (10/16/18). "Press Release: ERS Genomics and Syngulon Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Industrial Applications". Dublin & Seraing. 2018-10-16
Genedata AG. (10/16/18). "Press Release: Deep Learning-based Genedata Imagence for Automated High-Content Image Analysis Debuts at SLAS Conference". Basel. 2018-10-16
Revolution Medicines, Inc.. (10/16/18). "Press Release: Revolution Medicines Acquires Warp Drive Bio to Expand Drug Discovery Portfolio Focused on Frontier Oncology Targets". Redwood City, CA & Cambridge, MA. 2018-10-16
F-Star Biotechnology Ltd.. (10/15/18). "Press Release: F-star Appoints Dr Eliot Forster as Chief Executive Officer". Cambridge. 2018-10-15
Boehringer Ingelheim. (10/12/18). "Press Release: Boehringer Ingelheim Inaugurates Its New Global Centre for Veterinary Vaccine R&D in Lyon, France". Lyon. 2018-10-12
Miltenyi Biotec GmbH. (10/12/18). "Press Release: Miltenyi Biotec Acquires Microscopy Specialist LaVision BioTec". Bergisch Gladbach & Bielefeld. 2018-10-12
Curetis N.V.. (10/11/18). "Press Release: Curetis, Beijing Clear Biotech Expand Strategic Collaboration for Unyvero in Greater China". Amsterdam, Holzgerlingen & San Diego, CA. 2018-10-11
Metabolon, Inc.. (10/11/18). "Press Release: Metabolon Enters into Debt Agreement with Innovatus Life Sciences and East West Bank". Research Triangle Park, NC. 2018-10-11
EBD Group. (10/11/18). "Press Release: BIO-Europe 2018 to Bring 4,000 Life Science Leaders to Copenhagen November 5–7". Carlsbad, CA & Copenhagen. 2018-10-11
European Commission. (10/11/18). "Press Release: A New Bioeconomy Strategy for a Sustainable Europe. Commission Puts Forward an Action Plan to Develop a Sustainable and Circular Bioeconomy that Serves Europe's Society, Environment and Economy". Brussels. 2018-10-11
Qiagen N.V.. (10/11/18). "Press Release: Qiagen Launches Novel RNA-seq Library Preparation Solutions for Next-generation Sequencing". Hilden & Germantown, MD. 2018-10-11
Evotec AG. (10/11/18). "Press Release: Evotec and Celgene Expand iPSC Collaboration to Include additional Cell Lines. $6M Payment to Access additional Cell Lines". Hamburg. 2018-10-11
Bruker Corporation. (10/11/18). "Press Release: First Global Installation of 9.4 Tesla Preclinical MRI System Combined with PET at The German Cancer Research Center (DKFZ)". Billerica, MA. 2018-10-11
Forbion Capital Partners. (10/10/18). "Press Release: Forbion Co-leads $54m Series A Financing in Newly Formed Gotham Therapeutics". Naarden & Munich. 2018-10-10
CRISPR Therapeutics AG. (10/10/18). "Press Release: CRISPR Therapeutics and Vertex Announce FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease". Zug, Boston, MA & Cambridge, MA 2018-10-10
BRAIN AG. (10/10/18). "Press Release: Ludger Roedder to join BRAIN AG Management Board as Chief Business Officer (CBO)". Zwingenberg. 2018-10-10
Gotham Therapeutics Corporation. (10/10/18). "Press Release: Gotham Therapeutics Launches with $54 Million Series A". New York, NY. 2018-10-10
SmartDyeLivery GmbH. (10/10/18). "Press Release: New Financing Round Secures further Development of Innovative Nanotherapies". Erfurt, München & Jena. 2018-10-10
c-LEcta GmbH. (10/9/18). "Press Release: c-LEcta Accelerates Distribution of Denerase and Signs Sales Agreement with VWR". 2018-10-09
Hummingbird Diagnostics GmbH. (10/9/18). "Press Release: Jörg Debatin to Chair the Supervisory Board of Hummingbird Diagnostics GmbH". Heidelberg & Boston, MA. 2018-10-09
Lipotype GmbH. (10/8/18). "Press Release: Skin Lipidomics in Cosmetics and Dermatology. Lipotype Provides Royal DSM and Lipoid with Shotgun Skin Lipidomics". Dresden. 2018-10-08
Affimed N.V.. (10/8/18). "Press Release: Affimed Places AFM11 (CD19/CD3-Targeting T cell Engager) Phase 1 Program on Clinical Hold". Heidelberg. 2018-10-08
Epigenomics AG. (10/8/18). "Press Release: Capital Increase through Rights Issue with Subscription Rights of Existing Shareholders [NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAP 2018-10-08
Sphingotec GmbH. (10/8/18). "Press Release: Sphingotec Raises €20 Million from HBM and Wellington Partners". Hennigsdorf. 2018-10-08
Probiodrug AG. (10/5/18). "Press Release: Probiodrug Reports Management Changes". Halle (Saale). 2018-10-05
Bluebird Bio, Inc.. (10/5/18). "Press Release: Bluebird Bio Announces European Medicines Agency’s Acceptance of Marketing Authorization Application for LentiGlobin Gene Therapy for the Treatment of Transfusion-Dependent ß-Thalassemia". Cambridge, MA. 2018-10-05
Apceth Biopharma GmbH. (10/5/18). "Press Release: Apceth to Manufacture First Potential One-time Gene Therapy for Transfusion Dependent ß-Thalassemia". Munich. 2018-10-05
ERS Genomics Ltd.. (10/4/18). "Press Release: GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin. 2018-10-04
ERS Genomics Ltd.. (10/4/18). "Press Release: Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin. 2018-10-04
Evotec AG. (10/4/18). "Press Release: Evotec Signs Agreement with Sanofi to Advance Early Stage Academic Research into Novel Therapeutic Candidates". Hamburg. 2018-10-04
Evotec AG. (10/4/18). "Press Release: LAB150 Awards Its Second Drug Discovery Project from Canada’s Largest Research-based Hospital, The University Health Network (UHN)". Toronto. 2018-10-04
Oncgnostics GmbH. (10/2/18). "Press Release: Oncgnostics GmbH Retains Biotech Alliances International Inc. to Support Global Partnering and Distribution Strategy". San Francisco, CA & Jena. 2018-10-02
Curetis N.V.. (10/2/18). "Press Release: Curetis Secures Financing Facility of up to EUR 20 Million through the Issuance of Convertible Notes". Amsterdam, Holzgerlingen & San Diego, CA. 2018-10-02
GO Therapeutics, Inc.. (10/2/18). "Press Release: GO Therapeutics Enters into a License Agreement with Roche for New Glycotargeting Bispecific Cancer Treatment". Cambridge, MA. 2018-10-02
Genedata AG. (10/2/18). "Press Release: Genedata Bioprocess Offers Out-of-the-Box Integration with ambr Bioreactors". Basel. 2018-10-02
AiCuris Anti-infective Cures GmbH. (10/1/18). "Press Release: AiCuris to Cooperate with Cyclenium Pharma to Develop Novel Anti-Infectives". Wuppertal & Montreal. 2018-10-01
Forbion Capital Partners. (10/1/18). "Press Release: Forbion Closes Oversubscribed Fourth Life Sciences VC Fund at EUR 360 Million". Naarden & Munich. 2018-10-01
CeGaT GmbH. (10/1/18). "Press Release: Personalized Cancer Therapy. B. Braun and CeGaT Found Joint Venture CeCaVa". Melsungen & Tübingen. 2018-10-01
Taros Chemicals GmbH & Co. KG. (10/1/18). "Press Release: Taros Appoints Torsten Hoffmann as Senior Vice President Drug Discovery". Dortmund. 2018-10-01
Qiagen N.V.. (9/28/18). "Press Release: Qiagen Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer". Germantown, MD & Hilden. 2018-09-28
Tusk Therapeutics Ltd.. (9/28/18). "Press Release: Tusk Therapeutics to Be Acquired by Roche". Stevenage. 2018-09-28
next pagenext page 1 2 3 4 5 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top